Published in Vaccine Weekly, August 24th, 2005
"The frequency of meningitis due to penicillin-resistant Streptococcus pneumoniae (PRP) has increased in recent years, making treatment failure more likely. It is currently expected that pneumococcal conjugate vaccines might curb this trend. We investigated this issue using a mathematical model applied to the current prevalence of resistance and antibiotic exposure in the United States and in France," researchers in France report.
"Our main finding was that the level of antibiotic exposure may limit the effect of the vaccine," said Laura Temime and collaborators at INSERM...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly